RotaTeq

RotaTeq

vaccine, rotavirus

Manufacturer:

Merck Sharp & Dohme

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Live, oral pentavalent vaccine, rotavirus
Indications/Uses
Prevention of rotavirus gastroenteritis in infants & childn caused by the serotypes G1, G2, G3 & G4.
Dosage/Direction for Use
Vaccination series: 3 doses administered orally to infant. The 1st dose administered at 6-12 wk; the subsequent doses should be administered at min interval of 4 wk between each dose.
Administration
May be taken with or without food: Gently squeeze liqd into infant's mouth toward the inner cheek until dosing tube is empty.
Contraindications
Special Precautions
Individuals w/ malignancies or who are otherwise immunocompromised or those receiving immunosuppressive therapy. Infants w/ active GI illness, chronic diarrhea, growth retardation or history of congenital abdominal disorders or intussusception. Acute infection or febrile illness. Infant <6 wk.
Adverse Reactions
ATC Classification
J07BH01 - rota virus, live attenuated ; Belongs to the class of rota virus diarrhea viral vaccines.
Presentation/Packing
Form
RotaTeq vaccine (oral) 2 mL
Packing/Price
(pre-filled dosing tube) 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in